Literature DB >> 23647200

Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two-state and operational models.

David Roche1, Debora Gil, Jesús Giraldo.   

Abstract

Two-state and operational models of both agonism and allosterism are compared to identify and characterize common pharmacological parameters. To account for the receptor-dependent basal response, constitutive receptor activity is considered in the operational models. By arranging two-state models as the fraction of active receptors and operational models as the fractional response relative to the maximum effect of the system, a one-by-one correspondence between parameters is found. The comparative analysis allows a better understanding of complex allosteric interactions. In particular, the inclusion of constitutive receptor activity in the operational model of allosterism allows the characterization of modulators able to lower the basal response of the system; that is, allosteric modulators with negative intrinsic efficacy. Theoretical simulations and overall goodness of fit of the models to simulated data suggest that it is feasible to apply the models to experimental data and constitute one step forward in receptor theory formalism.
© 2013 The British Pharmacological Society.

Mesh:

Substances:

Year:  2013        PMID: 23647200      PMCID: PMC3831701          DOI: 10.1111/bph.12231

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation.

Authors:  D A Hall
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

Review 2.  G protein-coupled receptor allosterism and complexing.

Authors:  Arthur Christopoulos; Terry Kenakin
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 3.  Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.

Authors:  Peter Keov; Patrick M Sexton; Arthur Christopoulos
Journal:  Neuropharmacology       Date:  2010-07-15       Impact factor: 5.250

4.  How inverse can a neutral antagonist be? Strategic questions after the rimonabant issue.

Authors:  Jesús Giraldo
Journal:  Drug Discov Today       Date:  2010-05-04       Impact factor: 7.851

Review 5.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 6.  Systems biology: parameter estimation for biochemical models.

Authors:  Maksat Ashyraliyev; Yves Fomekong-Nanfack; Jaap A Kaandorp; Joke G Blom
Journal:  FEBS J       Date:  2009-02       Impact factor: 5.542

Review 7.  The asymmetric/symmetric activation of GPCR dimers as a possible mechanistic rationale for multiple signalling pathways.

Authors:  Xavier Rovira; Jean-Philippe Pin; Jesús Giraldo
Journal:  Trends Pharmacol Sci       Date:  2009-12-04       Impact factor: 14.819

8.  Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.

Authors:  Yelin Chen; Yi Nong; Cyril Goudet; Kamondanai Hemstapat; Tomas de Paulis; Jean-Philippe Pin; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2007-02-15       Impact factor: 4.436

9.  Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astroglia.

Authors:  Sophie J Bradley; Christopher J Langmead; Jeannette M Watson; R A John Challiss
Journal:  Mol Pharmacol       Date:  2011-02-14       Impact factor: 4.436

Review 10.  Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.

Authors:  Katie Leach; Patrick M Sexton; Arthur Christopoulos
Journal:  Trends Pharmacol Sci       Date:  2007-07-13       Impact factor: 14.819

View more
  5 in total

Review 1.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Authors:  Craig W Lindsley; Kyle A Emmitte; Corey R Hopkins; Thomas M Bridges; Karen J Gregory; Colleen M Niswender; P Jeffrey Conn
Journal:  Chem Rev       Date:  2016-02-16       Impact factor: 60.622

2.  A method for the quantification of biased signalling at constitutively active receptors.

Authors:  David A Hall; Jesús Giraldo
Journal:  Br J Pharmacol       Date:  2018-04-25       Impact factor: 8.739

3.  Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias.

Authors:  Frederick J Ehlert; Michael T Griffin
Journal:  J Pharmacol Toxicol Methods       Date:  2014-01-13       Impact factor: 1.950

4.  Quantitative Measure of Receptor Agonist and Modulator Equi-Response and Equi-Occupancy Selectivity.

Authors:  Rumin Zhang; Michael Kavana
Journal:  Sci Rep       Date:  2016-04-27       Impact factor: 4.379

5.  A mathematical model of parathyroid gland biology.

Authors:  Gudrun Schappacher-Tilp; Alhaji Cherif; Doris H Fuertinger; David Bushinsky; Peter Kotanko
Journal:  Physiol Rep       Date:  2019-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.